Video

Important Considerations in Iron Chelation Therapy

Any patient receiving regular blood transfusions will need to have the excess iron in their body removed, says Thomas D. Coates, MD. For patients who receive iron chelation therapy, careful monitoring is critical, as renal and neurologic side effects can occur. Iron chelation therapy can also result in low white blood cell counts, adds Coates. In children, it is important to recognize that iron is essential to their growth and development.

In Coates’ opinion, regulating the dose of an iron chelating agent should be based more on tolerance for the medication than on the body’s iron levels. Poor adherence remains an issue with these agents, adds Coates.

Related Videos
Minoo Battiwalla, MD, MS
Farrukh Awan, MD, discusses treatment considerations with the use of pirtobrutinib in previously treated patients with hematologic malignancies.
Francine Foss, MD
David C. Fisher, MD
Farrukh Awan, MD
Minoo Battiwalla, MD, MS
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss the role of genomic profiling in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss the treatment goals in secondary acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss factors for picking intensive chemotherapy vs other regimens in acute myeloid leukemia.
James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss dose intensity and sequencing of CPX-351 in secondary acute myeloid leukemia.